XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
$ in Millions
Issued capital
Capital surplus
Other capital reserves
Accumulated deficit
Impact of Adoption of IFRS 9 and IFRS 15
Accumulated deficit
Foreign currency translation
Total
Impact of Adoption of IFRS 9 and IFRS 15
Total
Non-controlling interests
Impact of Adoption of IFRS 9 and IFRS 15
Non-controlling interests
Impact of Adoption of IFRS 9 and IFRS 15
Total
Equity at beginning of period at Dec. 31, 2016 $ 2 $ 12,753 $ 753   $ (439) $ (7,109)   $ 5,960   $ 83   $ 6,043
Number of shares outstanding at beginning of period at Dec. 31, 2016 1,749,004,648                      
Profit /(loss) for the period         (283)     (283)   14   (269)
Other comprehensive income / (loss)     2     31   33   31   64
Total comprehensive income / (loss) for the period, net of tax     2   (283) 31   (250)   45   (205)
Dividends declared         (343)     (343)   (158)   (501)
Share-based payment transactions (in shares) 122,756                      
Changes in ownership interest in a subsidiary that do not result in a loss of control     (12)         (12)   (247)   (259)
Legal reserves     4   (4)              
Equity at end of period at Jun. 30, 2017 $ 2 12,753 747   (1,069) (7,078)   5,355   (277)   5,078
Number of shares outstanding at end of period at Jun. 30, 2017 1,749,127,404                      
Adjustments arising due to new accounting standards       $ 46     $ 46   $ 11   $ 57  
Equity, as adjusted $ 2 12,753 729   (1,418) (7,668)   4,398   (414)   3,984
Equity at beginning of period at Dec. 31, 2017 $ 2 12,753 729   (1,464) (7,668)   4,352   (425)   3,927
Number of shares outstanding at beginning of period at Dec. 31, 2017 1,749,127,404                      
Profit /(loss) for the period         (248)     (248)   28   (220)
Other comprehensive income / (loss)     (18)   (3) (259)   (280)   (87)   (367)
Total comprehensive income / (loss) for the period, net of tax     (18)   (251) (259)   (528)   (59)   (587)
Dividends declared         (299)     (299)   (92)   (391)
Other     3   (16) (9)   (22)   11   (11)
Equity at end of period at Jun. 30, 2018 $ 2 $ 12,753 $ 714   $ (1,984) $ (7,936)   $ 3,549   $ (554)   $ 2,995
Number of shares outstanding at end of period at Jun. 30, 2018 1,749,127,404